Takeda medicines are included in the Bridging the GAP series. This programme aims to help professionals better identify, diagnose, and treat ADHD in both adult patients and children and young people.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Takeda UK Ltd. at: AE.GBR-IRL@takeda.com